Why EFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%
Why EFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%
EFFECTOR Therapeutics Inc (NASDAQ:EFTR) shares are trading lower by 75% to $0.28 during Monday's session after the company announced that it has terminated its employees and will wind down its operations. Also, the company announced it plans to voluntarily request a delisting of its securities on the Nasdaq.
EFFECTOR Therapeutics Inc (納斯達克：EFTR) 股票在週一的交易中下跌75%，至0.28美元，此前公司宣佈將解僱員工並停止運營。此外，公司還宣佈計劃自願請求納斯達克退市。
This decision follows a special board meeting and the company expects delisting soon. Craig R. Jalbert, who the company says is experienced in managing distressed businesses, has been appointed as the new CEO, President, Treasurer, Secretary and sole board member to oversee the wind-down process.
該決定是在一次特別董事會會議後作出的，該公司預計很快將被除牌。據該公司稱，經驗豐富的Craig R. Jalbert已被任命爲新的CEO、總裁、財務主管、秘書和唯一的董事會成員，以監督停業過程。
According to data from Benzinga Pro, EFTR has a 52-week high of $22.50 and a 52-week low of $0.27.
根據Benzinga Pro的數據，EFTR的52周最高價爲22.50美元，52周最低價爲0.27美元。
譯文內容由第三人軟體翻譯。
